Cargando…

Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis

Detalles Bibliográficos
Autores principales: van Leeuwen, Jolijn R, Popov, Tamara, Obergfell, Achim, Rabelink, Ton J, Teng, Y K Onno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884459/
https://www.ncbi.nlm.nih.gov/pubmed/36721867
http://dx.doi.org/10.2147/BTT.S394843
_version_ 1784879723274305536
author van Leeuwen, Jolijn R
Popov, Tamara
Obergfell, Achim
Rabelink, Ton J
Teng, Y K Onno
author_facet van Leeuwen, Jolijn R
Popov, Tamara
Obergfell, Achim
Rabelink, Ton J
Teng, Y K Onno
author_sort van Leeuwen, Jolijn R
collection PubMed
description
format Online
Article
Text
id pubmed-9884459
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-98844592023-01-30 Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis van Leeuwen, Jolijn R Popov, Tamara Obergfell, Achim Rabelink, Ton J Teng, Y K Onno Biologics Research Letter Dove 2023-01-25 /pmc/articles/PMC9884459/ /pubmed/36721867 http://dx.doi.org/10.2147/BTT.S394843 Text en © 2023 van Leeuwen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Research Letter
van Leeuwen, Jolijn R
Popov, Tamara
Obergfell, Achim
Rabelink, Ton J
Teng, Y K Onno
Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
title Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
title_full Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
title_fullStr Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
title_full_unstemmed Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
title_short Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
title_sort preliminary assessment of safety and tolerability of avacopan during the early access program for anca-associated vasculitis
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884459/
https://www.ncbi.nlm.nih.gov/pubmed/36721867
http://dx.doi.org/10.2147/BTT.S394843
work_keys_str_mv AT vanleeuwenjolijnr preliminaryassessmentofsafetyandtolerabilityofavacopanduringtheearlyaccessprogramforancaassociatedvasculitis
AT popovtamara preliminaryassessmentofsafetyandtolerabilityofavacopanduringtheearlyaccessprogramforancaassociatedvasculitis
AT obergfellachim preliminaryassessmentofsafetyandtolerabilityofavacopanduringtheearlyaccessprogramforancaassociatedvasculitis
AT rabelinktonj preliminaryassessmentofsafetyandtolerabilityofavacopanduringtheearlyaccessprogramforancaassociatedvasculitis
AT tengykonno preliminaryassessmentofsafetyandtolerabilityofavacopanduringtheearlyaccessprogramforancaassociatedvasculitis